Liposoma provides liposomal formulations, specifically clodronate liposomes, control (PBS) liposomes and fluorescent liposomes. Our products are mainly used in studying various models of autoimmune diseases, transplantation, neurological disorders and gene therapy.

Our team of specialist and supporting staff has successfully served thousands of research groups worldwide. Our extensive knowledge and competences in developing liposomal formulations enables us to consult our customers effectively in the application of our products during experiments. Moreover, it enables us to actively run R&D projects in order to develop new liposomal formulations to improve and extend research opportunities for our customers.

Liposoma is supported by Nico van Rooijen PhD, Professor Gert Storm PhD and Bart Metselaar PharmD, PhD, RPh. Nico van Rooijen invented clodronate liposomes and has extensive knowledge and experience in consulting on the application of clodronate liposomes. Gert Storm is professor and key opinion leader in advanced drug delivery and liposomal drug targeting. Bart Metselaar is a registered pharmacist and world-renowned expert in liposome manufacturing and quality control.